Aktualności
MHRA: Advanced therapy medicinal products
04.01.2010
The updated section provides advice and guidance on the regulatory arrangements that apply to advanced therapy medicinal products (ATMPs). ...
New MHRA guidance for the naming of medicinal products
04.01.2010
MHRA has issued new naming policy guidance for product names with respect to invented names and qualifiers, umbrella segments, generic nomenclature and Braille requirements. ...
MHRA: New Variations Regulation - Latest guidelines and application form published
04.01.2010
Final versions of the European Commission (EC) procedural and classification guidelines, together with the new variation application form are now published ready for implementation of the new
...
CDMh: Guidance Document For Marketing Authorisation Holders on Submissions of Psurs Under The Eu Psur Work Sharing Scheme
18.12.2009
This document sets out the responsibilities of the Marketing Authorisation Holders with respect to the submission of PSURs under the work sharing scheme. The responsibilities of the National
...
CMDh: Phvwp and Cmd(H) Best Practice Guide for Work Sharing Concerning The Assessment Of Psurs of Products for Which an EU Harmonised Virtual Birth Date and Related Harmonised Data Lock Point Have Been Agreed
18.12.2009
This document sets outs the responsibilities of the P-RMS and P-CMS with respect to work sharing in the assessment of PSURs. The responsibilities of the MAHs are set out in a separate guidance
...
EMEA: Substances considered as not falling within the scope of Regulation (EC) No 470/20091, with regard to residues of veterinary medicinal products in foodstuffs of animal origin
18.12.2009
Regulation (EC) 470/2009 of 6 May 2009 lays down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin. The Regulation
...
EMEA: Explanatory note on fees payable to the European Medicines Agency
18.12.2009
Following the publication of the Rules for the implementation of Regulation (EC) No 297/95 on fees payable to the European Medicines Agency and other measures1 as last adopted by the Agency’s
...
EMEA: Mandate, Objectives And Rules of Procedure for the Pharmacovigilance Inspectors Working Group
18.12.2009
The PhV IWG will address all matters related directly or indirectly to PhV inspections and carry out the tasks described under section II. The key to its role is the development and implementation
...
Transitional provisions for implementation of Variation Regulation (EC) No 1234/2008
18.12.2009
Further to discussions between the EMEA, European Commission and the CMD(h), the following
practical guidance on the transitional provision and entry into force of the Variation Regulation, as
...
